wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q36104980-DDD598C7-5FC3-4D05-8063-E6F4F9C8029F
Q36104980-DDD598C7-5FC3-4D05-8063-E6F4F9C8029F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36104980-DDD598C7-5FC3-4D05-8063-E6F4F9C8029F
The Allelic Context of the C797S Mutation Acquired upon Treatment with Third-Generation EGFR Inhibitors Impacts Sensitivity to Subsequent Treatment Strategies.
P2860
Q36104980-DDD598C7-5FC3-4D05-8063-E6F4F9C8029F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36104980-DDD598C7-5FC3-4D05-8063-E6F4F9C8029F
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c257cb2b7ee49c676d0fd59b344dbe61970129a9
P2860
A phase 2 trial of dacomitinib (PF-00299804), an oral, irreversible pan-HER (human epidermal growth factor receptor) inhibitor, in patients with advanced non-small cell lung cancer after failure of prior chemotherapy and erlotinib.